Estimated SR&ED Credits
Health Technology and Medical Device innovation in Canada is focused on wearable diagnostics, robotic surgery assistants, and brain-computer interfaces. In 2026, the industry is pushing the boundaries of patient care through the development of point-of-care microfluidic devices and AI-driven smart prosthetics. These technologies require the seamless integration of hardware and software to ensure clinical-grade accuracy and patient safety. Canadian firms are also leading the way in “Digital Therapeutics,” where software is used as a medical device to treat neurological and chronic health conditions.
The SR&ED path for HealthTech often involves data integrity uncertainty and complex hardware-software integration. Eligibility arises when a company must develop custom algorithms for signal extraction from noisy biosensors or resolve latency issues in haptic feedback systems. Systematic investigation into the reliability and accuracy of these devices represents highly eligible R&D. These projects require rigorous documentation of every testing iteration and technical failure to prove that the work moved beyond standard medical engineering practices and met the high safety standards of the healthcare sector.
GrowWise offers specialized knowledge of both health regulations and SR&ED requirements. We help you document the technical roadblocks encountered while scaling your data-heavy health platforms. Our consultants work with your engineers to ensure that every hour of R&D is captured, from initial prototype to final clinical validation. By partnering with GrowWise, your HealthTech firm can secure the funding needed to move through the lengthy regulatory process and bring your life-changing medical devices to the global market.
